REQUEST A DEMO
Total
USD $0.00
Search more companies

SCL Science Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: SCL Science Inc. Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

SCL Science Inc. is a company based in South Korea, with its head office in Seoul. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on April 19, 2010. The total number of employees is currently 161 (2025). In its most recent financial highlights, the company reported a net sales revenue increase of 237.88% in Q12026. Over the same period, its total assets grew by 34.49%. The net profit margin of SCL Science Inc. increased by 58.37% in 2026.

Headquarters
1210, 1206, 2Cha, Ace Hitech City, 25, Seonyu-Ro 13-Gil, Yeongdeungpo-Gu
Seoul; Seoul;

Contact Details: Purchase the SCL Science Inc. report to view the information.

Website: http://www.innotherapy.com

Basic Information
Total Employees:
Purchase the SCL Science Inc. report to view the information.
Outstanding Shares:
Purchase the SCL Science Inc. report to view the information.
Registered Capital:
Purchase the SCL Science Inc. report to view the information.
Financial Auditors:
Purchase the SCL Science Inc. report to view the information.
Incorporation Date:
April 19, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
25.1%
Purchase this report to view the information.
3.9%
Purchase this report to view the information.
0.6%
Subsidiaries
(주)씨에이텍
Innotherapy America Inc
엔브이씨 2019 바이오헬스케어투자조합
Company Performance
Financial values in the chart are available after SCL Science Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
237.88%
Total Operating Revenue
257.23%
Operating Profit
84.69%
EBITDA
N/A
Net Profit/Loss for the Period
38.57%
Total Assets
34.49%
Total Equity
-14.79%
Operating Profit Margin
57.96%
Net Profit Margin
58.37%
Return on Equity (ROE)
1.71%
Debt / Equity
56.73%
Quick Ratio
-1.42%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?